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The main challenge in tissue engineering consists in understanding and controlling the growth 23 
process of in vitro cultured neotissues towards obtaining functional tissues. Computational 24 
models can provide crucial information on appropriate bioreactor and scaffold design but also on 25 
the bioprocess environment and culture conditions. In this study the development of a 3D model 26 
using the level set method to capture the growth of a microporous neotissue domain in a dynamic 27 
culture environment (perfusion bioreactor) was pursued. In our model, neotissue growth velocity 28 
was influenced by scaffold geometry as well as by flow induced shear stresses. The neotissue was 29 
modeled as a homogenous porous medium with a given permeability and the Brinkman equation 30 
was used to calculate the flow profile in both neotissue and void space. Neotissue growth was 31 
modeled until the scaffold void volume was filled thus capturing already established 32 
experimental observations, in particular the differences between scaffold filling under different 33 
flow regimes. This tool is envisaged as a scaffold shape and bioprocess optimization tool with 34 
predictive capacities. It will allow control fluid flow during long-term culture, whereby neotissue 35 
growth alters flow patterns, in order to provide shear stress profiles and magnitudes across the 36 








Skeletal Tissue Engineering (TE) strategies hold a great promise for the regeneration of bone and 44 
cartilage based on the combination of bioreactors, 3D biomaterials and mesenchymal stem cells 45 
(MSCs). MSCs are progenitor cells crucial for skeletal TE applications due to their ability to 46 
undergo osteogenic and chondrogenic differentiation under the influence of various biochemical, 47 
biophysical and, importantly, biomechanical cues. Perfusion bioreactors have been extensively 48 
employed for the expansion and differentiation of MSCs providing sufficient mass transport for 49 
cell growth and differentiation (Sikavitsas, Bancroft et al. 2005; Grayson, Marolt et al. 2011; 50 
Sonnaert, Papantoniou et al. 2014). Furthermore, shear stress can determine early stem cell 51 
lineage commitment (Song, Dean et al. 2013) but also promote terminal osteogenic 52 
differentiation of bone marrow, periosteum and adipose derived MSCs and enhance extracellular 53 
matrix (ECM) deposition (McCoy and O'Brien 2010; Rauh, Milan et al. 2011; Papantoniou, Chai 54 
et al. 2013).  There is a substantial body of literature illustrating the osteogenic effect of 55 
mechanical stimulation either due to fluid flow or mechanical compression (or stretching) on the 56 
differentiation of MSCs when cultured in dynamic environments seeded on 3D scaffolds in vitro 57 
(Wang and Chen 2013; Delaine-Smith and Reilly 2011).  58 
In scaffold-based perfusion bioreactor culture, 3D cell growth and neotissue formation has been 59 
observed to begin with 2D cell proliferation on the scaffold strut surface. Subsequently, cells 60 
bridge scaffold struts and start growing towards the pore void followed by ECM deposition. 61 
Eventually, 3D cell growth will result in scaffold void filling, something that has been studied 62 
recently using computed tomography imaging techniques (Voronov, VanGordon et al. 2013; 63 
Papantoniou, Sonnaert et al. 2014). The calculation of wall shear stress values in empty scaffold 64 
geometries are therefore indicative of the shear stress experienced by cells during early culture 65 
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time (Truscello, Schrooten et al. 2011). A current challenge to further advance and utilize 66 
computational modeling strategies in the TE field is to comprise a domain composed of cells and 67 
ECM (a growing permeable neotissue) on real 3D scaffold geometries. There are intriguing 2D 68 
studies investigating this (Sacco, Causin et al. 2011; Hossain, Bergstrom et al. 2014) however  it 69 
was recently shown that without the third dimension, model parameters were overestimated 70 
losing accuracy in the representation of neotissue growth (Nava, Raimondi et al. 2013). 71 
Computational fluid dynamics (CFD) modeling has been extensively used in the field of TE (for 72 
review see (Hutmacher and Singh 2008) (Hossain, Chen et al. 2012) (Patrachari, Podichetty et al. 73 
2012)). The quantification of flow-associated shear stresses as well as their spatial distribution 74 
within various 3D scaffold geometries has been thoroughly investigated in perfused bioreactor 75 
setups (Raimondi, Boschetti et al. 2004; Porter, Zauel et al. 2005; Boschetti, Raimondi et al. 76 
2006; Cioffi, Boschetti et al. 2006; Jungreuthmayer, Donahue et al. 2009; Maes, Ransbeeck et al. 77 
2009; Voronov, VanGordon et al. 2010). In previous studies, local shear stresses were deﬁned as 78 
a function of ﬂow rate of the culture medium, bioreactor conﬁguration, porosity and porous 79 
scaffold micro-architecture (Voronov, VanGordon et al. 2010; Pham, Voronov et al. 2012). Most 80 
3D CFD studies to date only use empty scaffold geometries to calculate shear stress magnitude 81 
and distribution across the empty scaffold surface i.e. wall shear stress. The aforementioned 82 
studies do not take into account the transient nature of the 3D neotissue domain as a result of 83 
neotissue growth which has been observed experimentally (Papantoniou, Sonnaert et al. 2013). 84 
There have been few attempts to capture 3D neotissue growth on scaffolds, limited to gradually 85 
increasing scaffold struts (Lesman, Blinder et al. 2010), representing the neotissue layer as an 86 
impermeable domain. A recent interesting study describes the growth of a ‘biomass’ domain 87 
5  
(similar to what we term neotissue in this study) whose growth was coupled to oxygen 88 
concentration and shear stress (Nava, Raimondi et al. 2013). 89 
In addition to flow associated shear stress, neotissue growth kinetics have been also linked to the 90 
geometric features of scaffolds. Pore size (Zeltinger et al. 2001b), pore shape (Knychala et al. 91 
2013), and more specific features such as local curvature (Rumpler et al. 2008; Gamsjager et al. 92 
2013) have been demonstrated to control cell fate both for in vitro (Rumpler et al. 2008; Guyot et 93 
al. 2014) and in vivo applications (Bidan et al. 2012).  94 
Building on our previous studies where we investigated the effect of local curvature on in vitro 95 
3D growth (Guyot et al., 2014) and where we used the evolving neotissue growth in a 3D 96 
scaffold to accurately determine the shear stress values in both the void space and the neotissue 97 
during the bioreactor culture process (Guyot et al., 2015), this study demonstrates the added value 98 
of using also the shear stress as a parameter that influences the neotissue growth. Hereto this 99 
study shows the development of a level-set based computational tool able to capture the 100 
difference in growth of a microporous neotissue domain in a dynamic culture environment 101 
(perfusion bioreactor) under different flow rates. Capturing this difference is only possible by the 102 
explicit incorporation of flow-induced shear stresses as a parameter in the calculation of the 103 
neotissue growth velocity (alongside the scaffold geometry which was already present (Guyot et 104 
al., 2014)).  This tool provides the ability to steer fluid flow during long term culture in order to 105 
provide given shear stress profiles and magnitudes across the whole scaffold volume. 106 
 107 Methods 108 
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In this section, the model describing the neotissue growth, the calculation of the flow-induced 109 
shear stresses and the influence of the latter on the former will be explained.  110 
Neotissue growth via the level set method 111 
The growth induced changes in the neotissue topology during the culture process can be seen as a 112 
moving interface between two different domains (Sethian 1999): in this study, one domain 113 
represents the neotissue volume  ߗ௡௧, and the other one is the void ߗ௩, separated by an interface 114 
߁, with a normal  ࢔ડ (see Fig 1B). The level set method (LMS) is a technique that has been 115 
developed to deal with this kind of moving interfaces and it is used in the context of this study to 116 
simulate the evolution of the frontline ߁ between neotissue and void space in a mesh-free 117 
manner.  The principle of the LSM consists in defining a signed distance function φ in ߗ =118 
ߗ௡௧ ∪ ߗ௩ with the following properties:  119 
 ൝߮ > 0 ݅݊ ߗ௡௧߮ < 0 ݅݊ ߗ௩߮ = 0 ݋݊ ߁  
(1) 
In order to capture the evolution of the moving interface ߁, the following transient advection 120 
equation is solved with a given growth velocity ࢜ࡳ and homogenous Neumann boundary 121 
condition (߲߮/߲࢔ = 0, with ࢔ being the normal to the computational domain ߗ). 122 
 ߲߮
߲ݐ + ࢜ࡳ ∙ ∇߮ = 0 ݅݊ ߗ . 
(2) 
With  ࢜ࡳ = ܸீ ∙ ࢔ડ,  and ࢔ડ = ∇ఝ|∇ఝ|. The expression of the growth velocity magnitude ܸீ  will be 123 
described later. The initial configuration of the distance function φ corresponds to a homogenous 124 
single cell layer over the scaffold struts with a thickness equal to 20 µm (Darling and Guilak 125 
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2008). The time discretization of equation (2) was done using the backward Euler method and the 126 
advection term was treated with the method of characteristics. For more details about the 127 
implementation, please refer to (Guyot, Papantoniou et al. 2014). 128 
Shear stress distribution 129 
During dynamic culture, the neotissue grows, eventually filling up the whole scaffold void. These 130 
changes affect the flow patterns developed, depending on the presence (or not) of neotissue and 131 
so the flow profile has to be treated differently in ߗ௡௧ and ߗ௩ (as described in detail in Guyot et 132 
al., 2015). In ߗ௩, due to a low Reynolds number (Re<1), the flow profile was approximated via 133 
the Stokes equation (3). In ߗ௡௧, the complex structure of the neotissue can be seen as a 134 
homogenous porous medium with a given permeability ܭ଴, leading to the flow profile being 135 
calculated with the Darcy equation (4). According to the definition of the LSM, the interface ߁ is 136 
never conforming to the computational mesh, resulting in difficulties to couple equation (3) and 137 
(4) together with suitable boundary conditions at the interface. To overcome this, the Brinkman 138 
equation (5) was used to calculate the flow profile in the whole domain  ߗ (see Fig 1C). A no-slip 139 
boundary condition was applied on the scaffold surface as well as on the chamber walls. The 140 
scaffold was placed at a sufficient distance from the inlet avoiding refluxes occurring at the 141 
entrance of the scaffold (Papantoniou, Guyot et al. 2014), so the boundary condition for the 142 
inflow was set to a Poiseuille profile with a velocity u corresponding to the given flow rate Q.  143 
൜−ߤ∆࢛ + ∇݌ = 0 in ߗ௩∇. ࢛ = 0 in ߗ௩  (3) 
൝
ߤ
ܭ଴ ࢛ + ∇݌ = 0 in ߗ௡௧∇. ࢛ = 0 in ߗ௡௧  
(4) 
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ቊ−ߤ∆࢛ + ∇݌ + ߤܭ ࢛ = 0 in ߗ∇. ࢛ = 0 in Ω  
(5) 
This technique can be seen as a penalization method, indeed, when K is equal to the neotissue 144 
permeability   (ܭ ≪ 1) in  ߗ௡௧, it makes the Stokes term in (5) negligible. At the contrary, when 145 
K is set to a very high value (ܭ ≫ 1) in ߗ௩, it leads to the Darcy term to be close to zero. To 146 
avoid numerical problems, this switch between the two values was implemented using a space 147 
and time dependent smeared out Heaviside function H (6), and K was updated according to this 148 
function (7) (ߝ = 1.5ℎ, with h the mesh size). 149 
 150 
ܪ(߮) = ൞







ߝ ቁ , −ߝ <  ߮ < ߝ1, ߮ > −ߝ
 
(6) 
ܭ(࢞) = 10ଷ଴(1 − ܪ) + ܭ଴ܪ (7) 
The parameter ܭ଴ was estimated using the random fibers theory approximation. In (Nabovati A. 151 
2009), the authors provide an approximation of the permeability of a porous media made of a 152 
random fiber web:   153 
 ܭ଴ = 0.491ߜଶටଵିట೎ଵିట − 1
ଶ.ଷଵ. (8) 
 154 
In this equation, ߰ represents the porosity of the media (neotissue, assumed to be equal to 90% in 155 
this study, which is in the range of porosities of soft tissues and hydrogels) and ߰௖ corresponds to 156 
a percolation threshold or a threshold porosity where flow is permitted (set to zero in this study). 157 
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Finally,  ߜ represents the micro-pore size of the neotissue and was set to 50 µm, assuming the 158 
pore size equal to half to one third of the size of a fully spread cell of the type used in this study 159 
(Eyckmans, Lin et al. 2012).  160 
In this study, we distinguished two different wall shear stresses acting on cells depending on their 161 
location. The first one (ܵ ௌܵ௨௥௙) is the shear stress acting on the interface ߁ due to the different 162 
flow profiles from either side and is calculated with the usual definition:  163 
 ܵܵ௦௨௥௙ = ඥ߬ଵଶଶ + ߬ଶଷଶ + ߬ଵଷଶ, ݓ݅ݐℎ     ߬௜௝ = ߤ ቆ߲ݑ௜߲ݔ௝ +
߲ݑ௝߲ݔ௜ቇ. 
(9) 
The second one ( ܵܵூ௡)  is the shear stress acting within the neotissue, it is associated with the 164 
interstitial flow through the micro-porous neotissue and is approximated following the method 165 
presented in (Whittaker, Booth et al. 2009). This method is based on the fact that the micro-166 
porous neotissue is assumed to be composed of cylindrical ducts of diameter ߜ. Since the Darcy 167 
equation just gives the average (Darcy) velocity u, the interstitial velocity magnitude uin is 168 
calculated  from results of equation (5) and is turned into a Poiseuille velocity profile (ݑ௣) in a 169 
cylindrical channel  in order to have an analytical expression of local wall shear stress (on the 170 
wall of the cylindrical ducts, representing here the micro-pores), allowing for the estimation of 171 
SSin. 172 
ݑ௜௡ = |࢛|/߰ (10) 
ݑ௣ ≈ 2ݑ௜௡ ቆ1 − ൬2ݎߜ ൰
ଶቇ (11) 







Neotissue growth velocity 174 
A key parameter of the study is the local growth velocity of the neotissue. In (Guyot, 175 
Papantoniou et al. 2014), this space dependent velocity was only depending on the local mean 176 
curvature of the interface as it has been shown in (Bidan, Kommareddy et al. 2012) or (Rumpler, 177 
Woesz et al. 2008). Another important growth influencing factor is the local shear stress on cells. 178 
In (Nava, Raimondi et al. 2013), authors present a biomass growth model for cartilage describing 179 
an interface moving in time in function of the fluid-induced shear stress and in (Chapman, 180 
Shipley et al. 2014) the authors introduce a growth model for cell aggregates in hollow fiber 181 
bioreactors where cell population growth increased or decreased depending on wall shear stresses 182 
experienced by cells. In this study, a similar approach is used and the local neotissue growth 183 
velocity ܸீ   is described as a function of both the mean curvature and the flow-induced shear 184 
stress: 185 
 ܸீ = ܣ ∙ ݂൫ܵܵ௦௨௥௙൯ ∙ ݃(ߢ). (13) 
The neotissue growth velocity parameter ܣ was estimated from the experimental data obtained 186 
for the low flow rate results obtained in (Papantoniou, Sonnaert et al. 2014) using a trial and error 187 
approach and was set equal to 4 ∙ 10ିଵସ m2/s.  As described extensively in (Guyot et al, 2014), 188 
the basis of the influence of curvature on the neotissue growth comes from the observation that 189 
neotissue grows faster where the curvature is higher and that it does not grow if the curvature is 190 
negative or equal to zero (Bidan, Kommareddy, et al. 2013).  The mean curvature influence 191 
function ݃(ߢ) can therefore be expressed mathematically as follows: 192 
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 ݃(݇) = ൜−ߢ ݂݅ߢ > 00 ݂݅ ߢ ≤ 0 , (14) 
where ߢ is the local mean curvature (κ = ∇ ∙ ࢔ડ) and the second row of equation (14) depicts that 193 
there is no growth when the curvature is null or negative. The negative sign in equation (14) 194 
comes from the fact that according to our definition of φ, the normal ࢔ડ points toward neotissue, 195 
so growth has to be towards the opposite of ∇߮. The surface shear stress influence function 196 
݂൫ܵܵ௦௨௥௙൯ (unit less) was inspired by (Nava, Raimondi et al. 2013) (Fig 1D) and defined as a 197 






ۓ 0.5 + 0.5 ∙ ܵܵ௦௨௥௙ܽଵ      0 ≤ ܵܵ௦௨௥௙ < ܽଵ1                                      ܽଵ ≤ ܵܵ௦௨௥௙ < ܽଶܵܵ௦௨௥௙ − ܽଷܽଶ − ܽଷ                  ܽଶ ≤ ܵܵ௦௨௥௙ < ܽଷ0                                                ܽଷ ≤ ܵܵ௦௨௥௙
 
(15) 
This function was established in order to have an optimal shear stress influence that enhances the 199 
growth (ܽଵ < ܵܵ௦௨௥௙ < ܽଶ), and a critical threshold (ܵܵ௦௨௥௙ > ܽଷ) above which shear stress 200 
inhibits the cells and growth cannot occur anymore, in this study ܽଵ, ܽଶ, ܽଷ were respectively set 201 
to 0.05, 0.15 and 0.2 Pa (Chapman, Shipley et al. 2014). Table 1 summarizes all the parameters 202 
used in the calculation of the neotissue growth velocity vG. 203 
 204 
Table 1: model parameters used for the calculation of the neotissue growth rate vG. 205 
Parameter Value References 
Neotissue porosity, ߰ 90 % (Guyot, Papantoniou et al, 
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2015) 
Neotissue micro-pore size, ߜ 50 µm (Guyot, Papantoniou et al, 
2015) 
Neotissue  growth rate, A 4 ∙ 10ିଵସ m2/s Determined from 
(Papantoniou, Sonnaert et al. 
2014) 
Minimal shear stress value 
enhancing neotissue growth, 
ܽଵ 
0.01 (Chapman, Shipley et al. 
2014). 
Maximal shear stress value 
enhancing neotissue growth, 
ܽଶ 
0.03 (Chapman, Shipley et al. 
2014). 
Critical shear stress value, ܽଷ 0.05 
 




The full model was implemented with the free partial differential equation solver FreeFem++ 208 
(Hecht 2012). The computational domain (see Fig 1A) chosen consisted of the part of the 209 
perfusion bioreactor chamber comprising the entire scaffold including 2mm of the chamber at 210 
each scaffold side. This was done in order to avoid numerical refluxes and was meshed with 211 
approximately 3 million tetrahedrons. The numerical problem was solved in parallel using a 12 212 
core facility. In order to avoid unnecessary computational effort, the Brinkman equation was 213 
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solved on only one quarter of the full mesh cut along the flow axis and with respect to 214 
symmetrical boundary condition. 215 
Summary of Experimental set-up 216 
In this study, results presented in (Papantoniou, Sonnaert et al. 2014) were used in a first 217 
calibration and validation set-up. The set-up of the experiment is briefly repeated below. Three-218 
dimensional additive manufactured open porous Ti6Al4V scaffolds (Ø = 6 mm, h = 6 mm, 219 
porosity = 73% ± 1%, strut diameter = 245 ± 2 mm and pore size = 755 ± 3 mm), produced on an 220 
in-house developed selective laser melting (SLM) machine (Van Bael, Kerckhofs et al. 2011) 221 
were used. Human Periosteal Derived Stem Cells (hPDCs, one of the known sources of MSCs) 222 
were isolated from periosteal biopsies of different donors as described previously (Eyckmans and 223 
Luyten 2006) and expanded in culture flasks. When a sufficient amount of these cells was  224 
produced in this 2D culture (number of population doublings = 15), cells were harvested by 225 
trypsinization with Tryple Express (Invitrogen) and  seeded on the scaffolds, which marked the 226 
start of the bioreactor experiment. The TE constructs were cultured in an in-house developed 227 
bioreactor for 14, 21 and 28 days under dynamic culture conditions (n = 9 per flow rate – 228 
triplicates per time point). Two different perfusion flow rates were used: 4 mL/min (Q1, high) and 229 
0.04 mL/min (Q2, low).  After culture, three constructs for each time point were prepared for 230 
contrast-enhanced nanofocus Computed Tomography (NanoCT) imaging (Kerckhofs 2013) 231 




Fig 1: Model setup. (A) Representation of the scaffold and the bioreactor chamber, the region of 235 
interest is delimited by two yellow circles. The scaffold is then removed from a cylinder 236 
representing the delimited area. Finally, a mesh is created in the computational domain. (B) 237 
Schematic representation of curvature driven neotissue growth using the level set method. (C) 238 
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Schematic representation of the Brinkman approximation used in this study.  (D) The influence of 239 
shear stress on the neotissue growth velocity in this study (right) is a combination of the 240 
continuous shape proposed by (Nava, Raimondi et al. 2013) and the values by (Chapman, Shipley 241 
et al. 2014) (middle).  242 
  243 
Results 244 
The model was run for different flow rates according to the experimental set up described in  245 
(Papantoniou, Sonnaert et al. 2014). Simulations show a significant difference between the two 246 
conditions regarding the total amount of neotissue that has been produced at different time points 247 
(Fig 2 and Fig 3). Indeed, under the high flow rate , the local shear stress acting on the neotissue 248 
interface is higher than for the lowest flow rate, resulting in an acceleration of neotissue growth. 249 
Although differences can be observed between the simulations and experiments, the simulations 250 
are capable of capturing the experimentally observed differences between the two flow rates in 251 
terms of volume filling (Fig 3B). The model was also able to compute quantitative data (shown in 252 
Fig 4) regarding important culture variables during neotissue growth such as pressure drop across 253 
the scaffold along the flow axis, average surface and inner shear stresses, giving an overview of 254 
different mechanical stimuli acting on cells over culture time.  255 
The pressure drop (Fig 4A) across the scaffold varied from almost 4 Pa in the first days of culture 256 
to 11 Pa at day 28 for the high flow rate Q1, while it ranged from 0.03 Pa to 0.08 Pa for the low 257 
flow rate Q2  in an equivalent period of time. The surface shear stresses (Fig 4B) and inside shear 258 
stresses (Fig 4C) differed by a factor of 100 between the two different flow rates.  For both flow 259 
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rates, the inner shear stress,  the stress acting on cells embedded into the neotissue, can be around 260 
3 (for early time points)  to 20 (for late time points) times bigger than the interface shear stress 261 
acting on cells at interface in contact with the free flow. Fig 5 shows how the flow regime 262 
changes from when the scaffold is almost empty (Fig 5A) to where it is partially filled (Fig 5B). 263 
Fig 6 depicts the local growth velocity ݒீ  showing the influence of the distributed shear stress as 264 
well as the local mean curvature of the surface. Maximal neotissue growth velocities of 3 and 7 265 
µm/day were obtained for the low and high flow rates respectively. 266 
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 267 
Figure 2: Neotissue growth (green) on scaffold (grey) at different time points for two different 268 
flow rates  and two different views (direction of flow rate is from bottom to top in side view). 269 
Gradual scaffold pore closure can be observed. Scale bar represents 1 mm. 270 
 271 
18  
272   Fig 3: Comparison between simulations and experimental results (Papantoniou, Sonnaert et al. 273 
2014). (B) Evolution of volume filling over culture time for the two different flow rates used in 274 
this study. Experimental results are presented through the mean and standard deviation (n=3). 275 
(A) Quantitative differences in volume filling between the different flow rates, indicating that the 276 
simulated differences are similar to those experimentally observed. 277 
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  278 
Fig 4: Mechanical characterization of the predicted tissue growth for flow rates Q2   279 
(0.04ml/min, left) and Q1 (4ml/min, right). (A) Pressure drop between the entrance and the exit of 280 
the scaffold. (B) Average neotissue surface shear stress. (C) Average inside neotissue shear 281 
stress.  Notice the difference in scale on the vertical axes between left and right figures. 282 
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  283 
Fig 5: Close-up view on a section of the scaffold illustrating the different flow profiles (u) at 284 
early (A) and late (B) time points (neotissue volume is indicated in pink). In image (A), the 285 
scaffold is almost empty, so the flow is mostly ruled by the Stokes equation leading to Poiseuille 286 
flow in the bottom part. In (B), the bottom part of the scaffold is completely filled with neotissue, 287 







  294 
Fig 6: Local distribution of the neotissue growth velocity ݒ௚ (m/s) at the neotissue-void interface 295 
at 28 days for flow rates Q2 (0.04ml/min, left) and Q1 (4ml/min, right). the neotissue is indicated 296 








Discussion  304 
Understanding spatiotemporal cell growth in dynamic cultures constitutes a challenge in TE, in 305 
particular the quantification, distribution and interplay between scaffold geometry, shear stress 306 
and neotissue growth. The present model provides a foundation that will allow the quantitative 307 
investigation of the effect of shear stresses on cell growth and ECM production, which today is 308 
still not well understood. The most important contribution of this study is the extension of a 309 
previously developed model of local curvature-dependent neotissue growth to incorporate the 310 
influence of the local shear stresses on the neotissue growth, on complete scaffolds in 3D. The 311 
importance of 3D models in comparison to 2D has been shown by (Nava, Raimondi et al. 2013), 312 
the latter suffering from a lack of accurate representation which leads to loss of information and 313 
an incorrect parameter estimation. 314 
Recent experimental observations have revealed that hPDCs (the MSC source used in this study) 315 
may grow in the third dimension by bridging scaffold struts, leading to complete filling of 316 
scaffold pores when cultured in perfusion bioreactors in glucose based growth medium (Sonnaert, 317 
Papantoniou et al. 2014) and in growth factor containing osteogenic medium (Papantoniou Ir, 318 
Chai et al. 2013). NanoCT imaging has been employed to confirm that complete pore closure 319 
could be obtained depending on bioreactor operating conditions (Papantoniou, Sonnaert et al. 320 
2014). Similar 3D cell growth behavior upon seeding on scaffolds has been also observed for 321 
other cell types such as human bone marrow MSCs (Zhao, Pathi et al. 2005; Li, Tang et al. 2009), 322 
primary fibroblasts (Joly, Duda et al. 2013) and cell lines such as MC3T3-E1 pre-osteoblast cells 323 
(Kommareddy, Lange et al. 2010). This opens the possibility to create 3D in vitro tissue-like 324 
structures where cells may grow independently of the initial scaffold surface allowing for the 325 
study of the interaction between cells and their own ECM and the culture environment. 326 
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Additionally, this means that when simulating the experimentally observed void filling due to 3D 327 
neotissue growth, models should take into account the specificity of the experimentally used cell 328 
type (Chapman, Shipley et al. 2014). In this work we attempt to investigate this for adult stem 329 
cell types in particular for hPDCs.  330 
Neotissue growth kinetics in 3D dynamic and scaffold-based culture set ups, has been linked with 331 
oxygen level (Zhao, Pathi et al. 2005), shear stress (Nava, Raimondi et al. 2013) and scaffold 332 
geometry - in particular curvature (Bidan, Kommareddy et al. 2013; Knychala, Bouropoulos et al. 333 
2013). In our study, oxygen was not investigated since for the flow rate and scaffold dimensions 334 
used in this work, taking into account the  the oxygen consumption rate of hPDCs (Lambrechts, 335 
Papantoniou et al. 2014), there is no significant oxygen drop detected from inlet to outlet. 336 
Therefore the assumption that the whole cell population is exposed to the same level of dissolved 337 
oxygen tension (atmospheric) seems to be justified. When other flow regimes and/or other cell 338 
types will be studied, this assumption has to be re-evaluated. An additional assumption was the 339 
existence of an initial single cell layer at the start of the simulations. This layer was assumed to 340 
be 20 µm based on 2D suspended MSC diameter values (Darling and Guilak 2008), leading to an 341 
initial filling percentage of 18 %. Provided that a high number of cells is used for cell seeding 342 
(Chen, Bloemen et al. 2011), a homogeneous distribution can indeed be achieved across the 343 
scaffold. This step has been studied in detail for regular geometry scaffolds (Melchels, Tonnarelli 344 
et al. 2011). The initial filling percentage is likely an overestimation of the real filling and is (in 345 
its current way of calculating) dependent on the available surface of the scaffold under study. 346 
With the currently used measurement technique (NanoCT) the experimental value for the initial 347 
filling cannot be obtained due to the absence of matrix produced by the cells immediately after 348 
seeding. This parameter therefore merits further study in future work.  Neotissue shrinkage/loss 349 
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due to cell death was not incorporated in the presented model, however, there is a possibility that 350 
this shrinkage/loss occurs for those cases were excessively harsh culture conditions are developed 351 
i.e. very low dissolved oxygen tension (anoxia) and glucose concentration or high lactate 352 
concentration (Flaibani, Magrofuoco et al. 2010). Further efforts are required in order to 353 
incorporate the aforementioned physico-chemical components in our model. However this is out 354 
of the scope of the present study, where geometry and fluid dynamics are the main regulators of 355 
neotissue growth.  356 
In this study neotissue growth velocity was coupled to the local scaffold topography (curvature) 357 
(Guyot, Papantoniou et al. 2014) and local fluid flow induced shear stress. Shear stress was 358 
modeled to enhance increasingly neotissue growth from 0 to ܽଵ reaching a maximum value 359 
between ܽଵ and ܽଶ (equal to 0.01 and 0.03 Pa respectively). The lower amount of neotissue 360 
observed at the periphery of the scaffolds is due to the low values of fluid flow induced shear 361 
stresses at that location. This in turn is due to the flow demonstrating a Poiseuille profile when 362 
entering the scaffold, thereby positively influencing to a greater extent the neotissue formation at 363 
the center of the scaffold. When the shear stress reaches  threshold ܽଷ equal to 0.05 Pa, its effect 364 
on neotissue growth was modeled to change into a prohibitive one with decreasing neotissue 365 
growth for increasing shear stresses beyond a3. Experimental observations of 0.015 Pa as an 366 
optimum shear stress level for human bone marrow MSCs cultured in perfusion bioreactors 367 
confirmed this hypothesis (Li, Tang et al. 2009). A similar range of shear stresses has been 368 
reported for human bone marrow MSCs by (Grayson, Bhumiratana et al. 2010) although these 369 
values referred to empty scaffold geometries. We have recently experimentally observed the 370 
adverse effects of excessive shear stress on neotissue growth by hPDCs in perfusion bioreactors 371 
resulting in inhomogeneous tissue engineered constructs (Papantoniou, Guyot et al. 2014). This 372 
was observed for shear stress values in excess of 0.05 Pa which is the threshold value used in this 373 
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study. Interestingly (McCoy, Jungreuthmayer et al. 2012) estimated a critical threshold for human 374 
bone MSC detachment from irregular scaffolds at 0.088 Pa closely matching the one used here, 375 
taking into account the differences in scaffold architecture and cell type.  376 
The growth velocity term A was estimated in a trial and error fashion based on in-house 377 
experimental observations (Papantoniou, Sonnaert et al. 2014) measuring neotissue growth on the 378 
simulated scaffold for the low flow rate Q2 . The prediction obtained for the high flow rate Q1 379 
shows an increase in volume filling, similar to the experimental data (Fig 3B). The discrepancy 380 
observed between experimental and computationally-derived neotissue growth kinetics seen in 381 
Fig 3 could be attributed to numerical and physical factors.  For the former (numerical factor), we 382 
did not go through an objective and rigorous optimization process to find the value for A because 383 
of the insufficient quantity of experimental data available.  In a follow-up study, dedicated 384 
experimental data will be generated to parametrize the model. As to the latter (physical factor), 385 
neotissue growth kinetics do not solely depend upon scaffold geometry and shear stress 386 
magnitude. The introduction in the model of additional physico-chemical parameters that are well 387 
known for their influence on neotissue growth such as dissolved oxygen tension (Grayson, Zhao 388 
et al. 2007; Dos Santos, Andrade et al. 2010), glucose concentration (Saki, Jalalifar et al. 2013) 389 
and lactate concentrations (Schop, Janssen et al. 2009) in the medium, could help to improve the 390 
agreement between experimentally and computationally determined values. Even though for the 391 
experiments used in this study (Papantoniou, Sonnaert et al. 2014), no global changes in oxygen 392 
tension were observed between the inlet and outlet for the flow rate and cell source used, the 393 
model allows to quantify these variable throughout the entire scaffold, potentially showing 394 
pockets of decreased oxygen tension (and neotissue growth) coming from improper perfusion due 395 
to local geometrical particularities. Additionally, the possibility that higher flow rates might lead 396 
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to the secretion of more ECM could also explain to a certain extent the differences in volume 397 
filling patters between simulations and experiments. 398 
In a very interesting recent study, neotissue was modeled in 3D by (Nava, Raimondi et al. 2013) 399 
using the arbitrary Lagrangian–Eulerian (ALE) method to implement mesh movement. However, 400 
the flow was only modeled in the void space, which is acceptable for the early growth phase, but 401 
is not suitable to simulate complete filling of the scaffold. In this study, we employed the level set 402 
method to represent neotissue growth as described previously in (Guyot, Papantoniou et al. 2014 403 
and Guyot et al. 2015). This method, separating the movement of the interface from the definition 404 
of the mesh allows tracking the neotissue kinetics until full scaffold pore filling is reached. A 405 
maximal neotissue growth velocity of 3 and 7 µm/day was obtained for the low and high flow 406 
rates respectively as seen in Fig 6. The average growth velocities from the present study are the 407 
same order of magnitude than the ones estimated in (Nava, Raimondi et al. 2013) which were in 408 
the order of 1 µm/day and higher than the values adopted in previous tissue growth models 409 
(Sacco, Causin et al. 2011). This could be due to the fact that chondrocytes modeled in that work 410 
are slow proliferating cells compared to hPDCs. 411 
Numerical predictions obtained in this study (Fig 4 and Fig 5) are in general agreement with 412 
published literature with regard to the range of shear stresses calculated at the neotissue 413 
interphase during neotissue growth (Boschetti, Raimondi et al. 2006; Cioffi, Boschetti et al. 2006; 414 
Lesman, Blinder et al. 2010; Nava, Raimondi et al. 2013). However shear stresses developed 415 
within the neotissue (SSin) were seen to be an order of magnitude higher than the surface shear 416 
stresses. It is interesting to note that the average values obtained for inner shear stress for the high 417 
flow rate in this work, reaching 0.7 Pa, compared closely to the ones determined for native bone 418 
(1–3 Pa) (Zeng, Cowin et al. 1994), closer than what has been reported to date for tissue 419 
engineered constructs. In this study it was assumed that the pores within the neotissue had a size 420 
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of 50 µm, this was justified, for our case study, for large hPDC cells whose size has been shown 421 
to range between 100-150 µm when fully spread (Eyckmans, Lin et al. 2012).  This value could 422 
become smaller upon 3D confluency when cells ECM secretion might lead to fuller neotissue 423 
structures. Interestingly, the calculated inner neotissue (microporous) shear stress magnitude for 424 
the selected neotissue pore size matched closely to those determined via single cell simulations 425 
(Jungreuthmayer, Donahue et al. 2009; Verbruggen, Vaughan et al. 2014; Zhao, Vaughan et al. 426 
2014). Empty scaffold simulations may be useful for early time points and have been successfully 427 
used to determine stem cell lineage commitment (Song, Dean et al. 2013) however for later 428 
culture time points these models seem to be insufficient.  429 
Using the whole scaffold geometry it was also possible to determine changing pressure drop 430 
values during neotissue growth and subsequent scaffold pore closure. The maximum pressure 431 
drop values obtained for the high flow rate, for completely full scaffolds, equaled to 11 Pa for the 432 
parameters of this study (cylindrical scaffold dimensions d = 6 mm, h = 6 mm; neotissue porosity 433 
90%, pore size = 50 µm). This value is close to pressure drop measured computationally in 434 
microporous polyester scaffolds in flow through perfusion bioreactors (ΔP = 46 Pa, scaffold h = 435 
20 mm, d = 100 mm, flow rate  10 ml/min (Podichetty, Bhaskar et al. 2014)) but also with 436 
experimentally measured pressure drop values for chitosan-gelatin scaffolds (with 80-92 % 437 
porosity and pore size ~100 µm, d = 100 mm, h = 2 mm (Podichetty, Dhane et al. 2012)). 438 
Pressure drop is a parameter that can be measured online during bioreactor culture and, when 439 
linked to this whole-scaffold model, could provide a non-invasive readout to monitor neotissue 440 
growth in perfusion bioreactors. The continuous secretion of ECM, in particular upon reaching 441 
3D ‘confluency’, is expected to lead a decrease in neotissue permeability. This will occur mostly 442 
towards the later stages of perfusion culture. To achieve this in the present model a time-443 
dependent parameter could be coupled to the porosity parameter making it decrease over time, 444 
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reflecting ECM deposition. This could be experimentally validated by measuring pressure drop 445 
across the tissue engineered construct over time, for fixed flow rates.  446 
Scaffold design in perfusion bioreactors can affect neotissue growth in two ways. First, due to 447 
their geometry, the scaffolds provide topographies that will enhance 3D cell growth and neotissue 448 
formation (Melchels, Barradas et al. 2010; Van Bael, Chai et al. 2012). Second, their design will 449 
define fluid flow patterns throughout the entirety of the scaffold affecting the mechanical stimuli 450 
exerted on the cells (Hutmacher and Singh 2008) and the resulting growth kinetics. The 451 
computational tool developed in this study could be used to assess biomechanical regimes that 452 
will develop in a particular scaffold during neotissue growth but also to evaluate the effect of 453 
specific geometries using scaffold CAD designs on these regimes. This model could also suggest 454 
‘ideal’ geometries where shear stress variation exerted on cells across the scaffold could be 455 
minimized, resulting thus in a more homogeneous cell population phenotype. The spatiotemporal 456 
mapping of shear stress levels will allow to more accurately link phenotypic responses in 457 
bioreactors (Gomes, Sikavitsas et al. 2003; Yu, Botchwey et al. 2004; Grayson, Marolt et al. 458 
2011) with the experienced biomechanical microenvironment. Moreover, already observed 459 
phenomena such as shear stress dependent ECM secretion and mineralization (Gomes, Sikavitsas 460 
et al. 2003; Sikavitsas, Bancroft et al. 2005; Papantoniou, Chai et al. 2013) could be also linked 461 
to the experienced microenvironment. For their validation such models will require 3D tools of 462 
high resolution such as NanoCT as presented here or synchrotron X ray microCT as reported 463 
elsewhere (Albertini, Giuliani et al. 2009; Voronov, VanGordon et al. 2013). 464 
 465 
Conclusion 466 
In this study, a 3D model of microporous neotissue growth in a dynamic culture environment was 467 
presented in which the neotissue growth velocity depends on scaffold geometry and fluid flow 468 
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induced shear stress. The obtained simulation results showed a correspondence with established 469 
experimental observations. Although the model can be extended to include additional 470 
determinants of the growth process, in its current state it is already able to act as a scaffold shape 471 
and bioprocess optimization tool, allowing for a control of the flow-induced mechanical 472 
stimulation and growth of the neotissue.  473 
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